VBI-1901

DB18476Investigational

VBI-1901 is a bivalent cytomeglaovirus gB/pp65 enveloped virus-like particles.

Mechanism: Pharmacologically active on 65 kDa phosphoprotein
Curator reviewed
Code names: VBI-1901

Resolves to

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with VBI-1901, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.